Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007
November 27, 2024 03:00 ET
|
Lin BioScience, Inc.
Fast Track designation indicates LBS-007’s potential in filling the unmet medical need of acute leukemiaLBS-007 is the Company’s investigational medicinal product for the treatment of acute leukemiaA...